Ayala Pharmaceuticals Inc (ADXS)

[mypekeispooped]

Thanks, hov. Much appreciated. I suppose the <50% drop in the Part B is encouraging, also. Still a small number (29) but, again, median has not reached. I'm hoping the correlative biomarker analysis will shed light on who might best respond to the treatment. Supposedly we'll know this quarter but met timelines are hit and miss with Advaxis.